UNSPSC 51151655: Otenzepad

This classification denotes an antimuscarinic agent with the molecular formula C24H31N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OM7J0XAL0S, chemically known as 6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((2-((diethylamino)methyl)-7-piperidinyl)acetyl)- but generally known as otenzepad, which bears US NIH Compound Identifier 107867. European Medicines Agency schedules Otenzepad in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09478MIG.

UNSPSC 51151655 Otenzepad, a Commodity code, describes pharmaceutical products that state and local governments procure for community health and emergency response initiatives. The scope of work under this code includes naloxone (an opioid-overdose reversal medication) and safe drug deactivation systems supplied in bulk for distribution through public health departments, county community health facilities, and emergency services. State and local issuing bodies soliciting under this code include county health departments and community health agencies focused on substance-abuse prevention and overdose-response programs.

Seminole County, Florida represents the primary recent buyer under this code. In June 2026, Seminole County released IFB 60459723LAS seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing, and standard compliance requirements including E-Verify, drug-free workplace certification, and workers' compensation insurance. Potential FEMA funding introduces additional federal environmental and regulatory compliance obligations. Bidders must include all shipping and delivery costs in their proposals and submit electronically through the county's e-procurement portal.